Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, February 18, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

 MIDDAY BREAKOUTS REPORT - FRIDAY, JUNE 17TH, 2022
Previous Mid Day Report Next Mid Day Report >>>

DOW 29806.66 -120.41 (-0.40%) | NASDAQ 10737.11 91.01 (0.85%) | S&P 500 3660.53 -6.24 (-0.17%)
Time of Screening : 6/17/2022 12:14:11 PM         Report Released : 6/17/2022 1:08:44 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 57.5% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page
Symbol/Exchange
Company Name
Industry Group
PRICE CHANGE
(%Change)
Day High Volume
(% DAV)
(50 DAV)
52 Wk Hi
% From Hi
Date
Featured
Price
Featured
Pivot Point
Max Buy
LLY - NYSE
Lilly Eli & Co
$293.78 +5.71
1.98%
$300.99 1,874,236
62.96% of 50 DAV
50 DAV is 2,977,000
$324.08
-9.35%
5/16/2022 $302.46 PP = $314.10
MB = $329.81
Most Recent Note - 6/17/2022 12:31:37 PM
G - Quietly slumped below its 50 DMA line ($298) which may now act as resistance. A rebound above the 50 DMA line is needed for its outlook to improve. The fact-based investment system discourages any new buying until a follow-through day confirms a new market uptrend (M criteria).
>>> The latest Featured Stock Update with an annotated graph appeared on 6/6/2022. Click here.
View all notes | Alert me of new notes | Company Profile | SEC | News | ChartC A N S L I M

Symbol - Exchange - Industry Group
Company Name
Last Chg Day
High
52 WK Hi % From Hi Volume
% DAV
DAV
AFG - NYSE - INSURANCE - Property & Casualty Insurance
American Financial Group
$131.99 +2.52
1.95%
$133.60 $143.84 -8.24% 302,625
84.30%
359,000
Most Recent Note for AFG - 6/17/2022 12:15:51 PM
Stalled after touching a new all-time high last week and pulled back testing support at its 200 DMA line ($130.72). Reported strong results in recent quarterly comparisons through Mar '22 versus the year ago periods but with lackluster sales revenues growth. Annual earnings (A criteria) had a downturn in FY '20, not a match with the fact-based investment system's guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
AMGN - NASDAQ - DRUGS - Biotechnology
Amgen Inc
$234.60 +3.89
1.69%
$236.34 $258.45 -9.23% 2,260,684
71.59%
3,158,000
Most Recent Note for AMGN - 6/17/2022 12:16:49 PM
Slumped well below its 50 DMA line with higher volume behind recent losses. Reported earnings +15% on +6% sales revenues for the Mar '22 quarter versus the year ago period. Prior quarters were not strong and steady above the +25% minimum earnings guideline (C criteria). It has a slow and steady annual earnings (A criteria) history. Not a match with the fact-based investment system's fundamental guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CB - NYSE - INSURANCE - Property & Casualty Insurance
Chubb Corp
$188.39 -0.81
-0.43%
$190.76 $218.99 -13.98% 1,706,808
98.04%
1,741,000
Most Recent Note for CB - 6/17/2022 12:18:26 PM
Slumped well below its 200 DMA line with a gap down and volume-driven loss on the prior session. Fundamental concerns remain since last noted with caution in the 1/14/16 mid-day report - "Quarterly and annual earnings history (C and A criteria) is not a match with the fact-based investment system's guidelines. On 3/28/2006 it was dropped from the Featured Stocks list."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CI - NYSE - Medical-Managed Care
Cigna Corp
$244.34 -3.96
-1.59%
$251.82 $273.58 -10.69% 978,742
62.30%
1,571,000
Most Recent Note for CI - 6/17/2022 12:20:23 PM
Recent losses with higher volume violated its 50 DMA line ($258) and undercut prior lows triggering technical sell signals. A rebound above the 50 DMA line is needed for its outlook to improve. It was dropped from the Featured Stocks list on 6/13/22 amid widespread market weakness (M criteria).
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CLR - NYSE - ENERGY - Oil &; Gas Drilling &; Explorati
Continental Res Inc
$65.69 -3.81
-5.48%
$69.46 $75.49 -12.98% 1,540,445
85.34%
1,805,000
Most Recent Note for CLR - 6/17/2022 12:21:17 PM
Pulled back from its 52-week high and recent intra-day price swings have been wider than usual. Noted with caution in prior mid-day reports - "Reported earnings +244% on +49% sales revenues for the Mar '22 quarter versus the year ago period. Prior earnings history has been erratic and not a match with the investment system's guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CNC - NYSE - HEALTH SERVICES - Health Care Plans
Centene Corp
$76.64 +0.00
0.00%
$79.30 $89.92 -14.77% 1,809,045
66.46%
2,722,000
Most Recent Note for CNC - 6/17/2022 12:22:45 PM
Slumped below its 200 DMA line with recent volume-driven losses. Reported earnings +12% on +24% sales revenues for the Mar '22 quarter versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). Annual earnings history (A criteria) has been steady. Shares split 2:1 on 2/07/19 and also 2:1 back on 2/20/15. Completed a new Public Offering on 5/03/18.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
EGY - NYSE - ENERGY - Independent Oil & Gas
Vaalco Energy Inc
$7.57 -0.47
-5.85%
$8.37 $8.77 -13.68% 1,509,664
95.55%
1,580,000
Most Recent Note for EGY - 6/17/2022 12:24:34 PM
Near its 52-week high churning higher volume while recently consolidating near prior highs and above its 50 DMA line ($7.11). For the Mar '22 quarter it reported earnings +140% on +73% sales revenues versus the year ago period. Erratic quarterly and annual earnings (C and A criteria) history is a concern. Low priced stocks are riskier choices which the investment system guidelines say should be avoided unless all criteria are soundly satisfied.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
EQNR - NYSE - Oil&Gas-Integrated
Equinor ASA Adr
$33.71 -0.72
-2.08%
$35.60 $39.15 -13.91% 4,150,596
112.15%
3,701,000
Most Recent Note for EQNR - 6/17/2022 12:26:13 PM
Volume-driven losses have it sputtering below its 50 DMA line ($36). Noted with caution in prior mid-day reports - "Recent quarterly comparisons through Mar '22 showed strong sales revenues and earnings increases over the year ago period. Annual earnings history has been erratic."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
FRBA - NASDAQ - Banks-Northeast
First Bank NJ
$13.89 +0.04
0.29%
$13.98 $15.90 -12.64% 22,741
66.89%
34,000
Most Recent Note for FRBA - 6/17/2022 12:27:39 PM
Slumped below its 50 and 200 DMA lines recently after hovering in a tight range for many months. Reported Mar '22 quarterly earnings -16% on -4% sales revenues versus the year ago period. Prior quarterly comparisons were above the +25% minimum earnings guideline (C criteria) but with sub par sales revenues growth. Up and down annual earnings (A criteria) history is not a match with the fact-based investment system's guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
GO - NASDAQ - Retail-Discount&Variety
Grocery Outlet Hdg Corp
$39.70 -0.75
-1.85%
$41.36 $40.64 -2.31% 747,597
68.52%
1,091,000
Most Recent Note for GO - 6/17/2022 12:28:47 PM
Rebounding towards its highs after a deep slump over the past year. Prior mid-day reports noted - "Earnings history (C and A criteria) is not a match with the fundamental guidelines of the fact-based investment system."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
LOPE - NASDAQ - DIVERSIFIED SERVICES - Education &; Training Services
Grand Canyon Education
$87.07 +2.86
3.40%
$87.43 $102.04 -14.67% 207,914
59.07%
352,000
Most Recent Note for LOPE - 6/17/2022 12:49:19 PM
Slumping below its 200 DMA line with recent losses. Reported earnings +0% on +3% sales revenues for the Mar '22 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum guideline (C criteria) of the fact-based investment system.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
MANT - NASDAQ - COMPUTER SOFTWARE & SERVICES - Business Software & Services
Mantech International
$94.52 -0.17
-0.18%
$95.00 $95.98 -1.52% 350,801
63.78%
550,000
Most Recent Note for MANT - 6/17/2022 12:49:31 PM
Gapped up on 5/16/22 following M&A news with The Carlyle Group Inc (CG). Reported Mar '22 earnings +1% on +7% sales revenues versus the year ago period, and prior quarterly comparisons were below the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been steady.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
MCD - NYSE - LEISURE - Restaurants
Mcdonalds Corp
$233.98 -1.21
-0.51%
$235.19 $271.15 -13.71% 1,742,612
61.36%
2,840,000
Most Recent Note for MCD - 6/17/2022 12:55:51 PM
Sputtering below its 200 DMA line in recent weeks along with the broader market (M criteria) weakness. Quarterly and annual earnings history (C and A criteria) are not a match with the fact-based investment system's fundamental guidelines. There are now 739.5 million shares outstanding. It was noted with caution in prior mid-day reports - "The global burger giant's stock is viewed as a 'safe haven' and longtime favorite for some institutional investors."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
MRK - NYSE - Medical-Ethical Drugs
Merck & Co Inc
$83.66 -1.24
-1.45%
$85.76 $94.92 -11.87% 8,932,772
75.13%
11,890,000
Most Recent Note for MRK - 6/17/2022 12:57:35 PM
Retreated from new all-time highs in May and slumped below its 50 DMA line ($88.55). Earnings improved +84% on +50% sales revenues in the Mar '22 quarter versus the year ago period, its 4th quarterly comparison above the +25% minimum earnings guideline (C criteria). Fundamental concerns remain after a downturn in in FY '20 earnings (A criteria).
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
NBN - NASDAQ - BANKING - Regional - Northeast Banks
Northeast Bancorp
$35.53 +0.68
1.95%
$37.37 $41.05 -13.45% 23,184
62.66%
37,000
Most Recent Note for NBN - 6/17/2022 12:59:08 PM
Reported Mar '22 quarterly earnings +4% on -55% sales revenues versus the year ago period, breaking a streak of strong quarterly comparisons. Finding support at its 200 DMA line.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
OSBC - NASDAQ - BANKING - Regional - Midwest Banks
Old Second Bancorp Inc
$13.80 +0.14
1.02%
$14.00 $15.68 -11.99% 124,509
61.33%
203,000
Most Recent Note for OSBC - 6/17/2022 1:00:42 PM
Pulled back from its 52-week high this week and undercut its 50 DMA line ($14.38) testing its 200 DMA line ($13.64). Prior mid-day reports cautioned members- "Reported Mar '22 quarterly earnings -10% on +55% sales revenues versus the year ago period. Fundamental are not a match with the fact-based investment system's guidelines (C and A criteria)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
PBH - NYSE - CONSUMER NON-DURABLES - Personal Products
Prestige Brands Holdings
$54.80 +0.35
0.64%
$55.28 $63.83 -14.15% 159,399
62.51%
255,000
Most Recent Note for PBH - 6/17/2022 1:02:03 PM
Met resistance near its 200 DMA line and it has been sputtering since the 5/10/22 mid-day report last noted - "Reported Mar '22 quarterly earnings +22% on +15% sales revenues versus the year ago period. Prior quarterly comparisons have not shown strong and steady earnings above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
RE - NYSE - INSURANCE - Accident & Health Insurance
Everest Re Group Ltd
$267.05 +2.05
0.77%
$268.87 $308.20 -13.35% 160,354
69.72%
230,000
Most Recent Note for RE - 6/17/2022 1:03:33 PM
Erratic earnings history leaves fundamental concerns. Slumped from its all-time high in March and recently violated its 200 DMA line.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
RLI - NYSE - INSURANCE - Property & Casualty Insurance
R L I Corp
$109.52 +0.31
0.28%
$111.08 $121.93 -10.18% 107,315
62.39%
172,000
Most Recent Note for RLI - 6/17/2022 1:03:50 PM
Reported Mar '22 quarterly earnings +84% on -8% sales revenues versus the year ago period. Annual earnings (A criteria) had a downturn in FY '18.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
THFF - NASDAQ - BANKING - Regional - Midwest Banks
First Financial Corp Ind
$43.96 -0.32
-0.71%
$44.63 $47.10 -6.68% 64,953
88.98%
73,000
Most Recent Note for THFF - 6/17/2022 1:05:19 PM
Found support near its 200 DMA line recently after volume-driven losses. Reported strong Mar '22 quarterly results. Prior quarterly earnings increases were not strong and steady above the +25% minimum guideline (C criteria).
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
TRV - NYSE - INSURANCE - Property & Casualty Insurance
Travelers Companies Inc
$160.99 -0.39
-0.24%
$162.59 $187.98 -14.36% 950,555
72.01%
1,320,000
Most Recent Note for TRV - 6/17/2022 1:06:25 PM
Slumped below its 200 DMA line during a streak of 7 consecutive losses. Noted with caution in prior mid-day reports - "Earnings history and sales revenues growth for this well-known Insurance - Property/Casualty/Title firm is not a match with the fact-based investment system's guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
VIVO - NASDAQ - DRUGS - Diagnostic Substances
Meridian Bioscience Inc
$27.77 +0.81
3.00%
$28.11 $29.00 -4.24% 201,508
61.25%
329,000
Most Recent Note for VIVO - 6/17/2022 1:07:14 PM
Still perched within striking distance of its 52-week high. The 6/08/22 mid-day report last cautioned members - "Quarterly earnings increases through Mar '22 versus the year ago periods have been below the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines. On 4/18/08 it was dropped from the Featured Stocks list."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
WWE - NYSE - LEISURE - General Entertainment
World Wrestling Entmnt
$62.48 -2.39
-3.68%
$64.67 $68.73 -9.09% 460,982
65.48%
704,000
Most Recent Note for WWE - 6/17/2022 1:08:37 PM
Testing support at its 50 DMA line ($61.89) again. While consolidating within striking distance of its 52-week high prior mid-day reports noted - "Reported Mar '22 quarterly earnings +51% on +27% sales revenues versus the year ago period, its 2nd strong quarterly comparison. The prior 4 quarterly earnings comparisons were negative, down from the year ago periods. Annual earnings (A criteria) history had a downturn in FY '19."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

 We appreciate any feedback members may wish to send via the inquiry form here.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us